BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 2516751)

  • 1. The incidence of infectious complications during the childhood ALL induction phase with BFM/ALL/NHL/86 protocol.
    Tontoli N; Pelliccia A; Guerriero A; Correra A; Montaldo A; Tancredi F
    Bone Marrow Transplant; 1989 Dec; 4 Suppl 3():103. PubMed ID: 2516751
    [No Abstract]   [Full Text] [Related]  

  • 2. Infections during induction therapy of childhood acute lymphoblastic leukemia--no association to mannose-binding lectin deficiency.
    Lausen B; Schmiegelow K; Andreassen B; Madsen HO; Garred P
    Eur J Haematol; 2006 Jun; 76(6):481-7. PubMed ID: 16494622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The treatment results in children diagnosed with non-Hodgkin's lymphomas and acute B-cell lymphoblastic leukemias treated by the BFM protocols. The report of the POGM (Pediatric Oncology Group of Madrid)].
    Vivanco Martínez JL; López Pérez J; Melero Moreno C; Torres Valdivieso MJ; Palacios López ME; Contra Gómez T; Martín Ramos N; Bernacer Borja M; Gil López C; Valverde Moreno F
    An Esp Pediatr; 1998 Dec; 49(6):603-8. PubMed ID: 9972623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment of infantile acute lymphoblastic leukemia with protocol ALL-BFM 83].
    Aracil Santos FJ; Bernacer Borja M; López Pérez J; Melero Moreno C; Valverde Moreno F; Gil Gil C; Contra Gómez T; Martín Ramos N
    An Esp Pediatr; 1989 Oct; 31(4):362-7. PubMed ID: 2627059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Infections during the induction treatment of acute lymphoid leukemia (ALL). The importance of preventive measures].
    Rodriguez Pedroso EC; Cuni Torriente L; González Otero A; Svarch E; Delgado C
    Rev Cubana Enferm; 1988; 4(1-2):120-30. PubMed ID: 3238112
    [No Abstract]   [Full Text] [Related]  

  • 6. [Testicular recurrence of acute lymphoblastic leukemia in children treated by BFM 81 83 protocol. Report of the Polish Group for the Treatment of Leukemia and Other Lymphatic Diseases in Children].
    Koehler M; Bubała H; Daszkiewicz P; Newecka-Samól T; Rodziewicz B; Rytlewska M; Skrobowska A; Sońta-Jakimczyk D; Trendowska D
    Pol Tyg Lek; 1988 Dec; 43(50):1615-8. PubMed ID: 3256802
    [No Abstract]   [Full Text] [Related]  

  • 7. [Studies of childhood non-Hodgkin's lymphoma--treatment results with the CCLSG NHL 960 protocol. Children's Cancer and Leukemia Study Group (CCLSG)].
    Tsurusawa M; Katano N; Hirota T; Ito M; Yanase T; Asami K; Koizumi S; Nakayama M; Miyawaki T; Suzumiya J; Nishikawa K; Mugisima H; Horikoshi Y; Hatae Y; Iwai A; Anami K; Kikuchi M; Osima K; Kaneko Y; Kataoka S; Tanaka A; Chin M; Taga T; Watanabe A; Fujimoto T
    Rinsho Ketsueki; 1998 Nov; 39(11):1092-8. PubMed ID: 9866420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Childhood acute lymphoblastic leukemia presenting with severe hepatic dysfunction.
    Belgaumi AF; Hudson MM
    Med Pediatr Oncol; 2001 Aug; 37(2):142-4. PubMed ID: 11496355
    [No Abstract]   [Full Text] [Related]  

  • 9. [Intensification of chemotherapy in maintenance therapy and in periodic reinduction of remission in high-risk childhood ALL].
    Indiano JM; Echaniz I; Humayor J; Delgado A
    An Esp Pediatr; 1988 Oct; 29 Suppl 34():94-8. PubMed ID: 3214047
    [No Abstract]   [Full Text] [Related]  

  • 10. Malignant non-Hodgkin's lymphoma of childhood and adolescence in Austria--therapy results between 1986 and 2000.
    Attarbaschi A; Mann G; Dworzak M; Trebo M; Urban C; Fink FM; Horcher E; Reiter A; Riehm H; Gadner H;
    Wien Klin Wochenschr; 2002 Dec; 114(23-24):978-86. PubMed ID: 12635465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Our experience in the treatment of acute lymphoblastic leukemias (ALL) having different risk levels with the BFM-83 therapeutic protocol].
    Bernacer M; Aracil J; Contra T; Gil C; López J; López-Ibor B; Martín N; Melero C; Valverde F; Vecilla C
    An Esp Pediatr; 1988 Oct; 29 Suppl 34():68-72. PubMed ID: 3214042
    [No Abstract]   [Full Text] [Related]  

  • 12. [DNA index and proliferative activity of blastic cells in childhood ALL].
    Peregud-Pogorzelski J; Fydryk J; Krygier-Stojałowska A; Urasiński T; Kamieńska E
    Acta Haematol Pol; 1995; 26(1):73-9. PubMed ID: 7747566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical study on mitoxantrone contained regimen for treatment of newly diagnosed childhood acute lymphoblastic leukemia].
    Wang WQ; Liu XY; Liu LQ
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2004 Oct; 29(5):602-3. PubMed ID: 16137060
    [No Abstract]   [Full Text] [Related]  

  • 14. [Childhood leukemia from the perspective of 15 years of its intensive treatment].
    Radwańska U
    Pediatr Pol; 1988 Nov; 63(11):689-92. PubMed ID: 3253654
    [No Abstract]   [Full Text] [Related]  

  • 15. Treatment of children with acute lymphoblastic leukemia in India using a BFM protocol.
    Bajel A; George B; Mathews V; Viswabandya A; Kavitha ML; Srivastava A; Chandy M
    Pediatr Blood Cancer; 2008 Nov; 51(5):621-5. PubMed ID: 18688848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of reduction of therapy on infectious complications in childhood acute lymphoblastic leukemia.
    Graubner UB; Porzig S; Jorch N; Kolb R; Wessalowski R; Escherich G; Janka GE
    Pediatr Blood Cancer; 2008 Feb; 50(2):259-63. PubMed ID: 17635005
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Use of monoclonal antibodies in acute lymphoblastic leukemia in children. II. Clinical picture and prognosis in specific immunological subgroups].
    Kołecki P; Radwańska U
    Pediatr Pol; 1988 Nov; 63(11):698-702. PubMed ID: 3253656
    [No Abstract]   [Full Text] [Related]  

  • 18. Treatment of childhood acute lymphoblastic leukaemia with the BFM regimen.
    Kudva GC; Chandy M; Raghupathy P; Dennison D; Srivastava A; Bhushan V; Singh R
    Indian J Cancer; 1994 Jun; 31(2):78-85. PubMed ID: 7927453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cough and fever in a child with leukaemia.
    Jenney ME
    Paediatr Respir Rev; 2000 Sep; 1(3):296, 299-300. PubMed ID: 15326733
    [No Abstract]   [Full Text] [Related]  

  • 20. Superiority of allogeneic hematopoietic stem-cell transplantation compared with chemotherapy alone in high-risk childhood T-cell acute lymphoblastic leukemia: results from ALL-BFM 90 and 95.
    Schrauder A; Reiter A; Gadner H; Niethammer D; Klingebiel T; Kremens B; Peters C; Ebell W; Zimmermann M; Niggli F; Ludwig WD; Riehm H; Welte K; Schrappe M
    J Clin Oncol; 2006 Dec; 24(36):5742-9. PubMed ID: 17179108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.